| Title | Interferon alfacon 1 inhibits SARS-CoV infection in human bronchial epithelial Calu-3 cells. | | Author(s) | Kumaki Y, Day CW, Wandersee MK, Schow BP, Madsen JS, Grant D, Blatt LM, Barnard DL | | Institution | Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Science, Utah State University, 5600 Old Main Hill, Logan, UT 84322-5600, USA. | | Source | Biochem Biophys Res Commun 2008 Apr 9. | | Abstract | The primary targets for SARS-CoV infection are the epithelial cells in the respiratory and intestinal tract. The angiotensin-converting enzyme 2 (ACE-2) has been identified as a functional receptor for SARS-CoV. ACE-2 has been shown to be expressed at the apical domain of polarized Calu-3 cells. In this report, interferon alfacon 1 was examined for inhibitory activities against SARS-CoV on human lung carcinoma epithelial Calu-3 cell line and the other three African green monkey kidney epithelial cell lines. Interferon alfacon 1 demonstrated significant antiviral activity in neutral red uptake assay and virus yield reduction assay. The data might provide an important insight into the mechanism of pathogenesis of SARS-CoV allowing further development of antiviral therapies for treating SARS infections. | | Language | ENG | | Pub Type(s) | JOURNAL ARTICLE
| | PubMed ID | 18406349 |
|
